Interim COVID-19 vaccination coverage in the EU/EEA during the 2023-24 season campaigns : April 2024

In September 2023, ECDC updated its COVID-19 vaccination coverage data analysis process, in view of the evolving timing and objective of the 2023-24 season vaccination campaigns in the European Union/European Economic Area (EU/EEA). This report presents an interim description of COVID-19 vaccine coverage in the EU/EEA between 1 September 2023 and 15 April 2024. - During the reporting period, 27 of 30 EU/EEA countries reported data on COVID-19 vaccination coverage for at least one target group (people aged 60 years and above, people aged 80 years and above, healthcare workers, individuals with chronic conditions, pregnant women). - During this period, approximately 28.1 million people aged 60 years and above received one COVID-19 vaccine dose. Approximately seven million people aged 80 years and above received one COVID-19 vaccine dose. - Among the 27 reporting countries, six countries reported a vaccination coverage ≥50% for the age group 60 years and above, while nine countries reported a vaccination coverage ≥50% for the age group 80 years and above. - The median COVID-19 vaccination coverage among people aged 60 years and above was 12.0% (range: 0.01-66.1%), with high variation among countries. For people aged 80 years and above, the median coverage was 17.1% (range: 0.01-89.3%), with high variation among countries. - Most of the approximately 31 million COVID-19 vaccine doses administered in the EU/EEA during this period in the overall population were the Comirnaty Omicron XBB.1.5 (Pfizer BioNTech) vaccine (around 25.5 million doses; 82.1% of the total doses administered); for 14.5% of the doses, the product was reported as unknown. - These preliminary results must be interpreted with caution. Higher degrees of data consolidation and data completeness are expected in the coming months.